Covaxin for children above 2 years will be available after September
New Delhi : In a big news to safeguard children against coronavirus, Covaxin for kids above 2 years is likely to be made available by September this year.
Delhi AIIMS director Randeep Guleria, in an interview with India Today, revealed that the data for Covaxin for children for phase 2 and phase 3 trials will be available by September and the approval for the same will come in the same month.
Giving further details, the COVID task Force member said that if Pfizer-BioNTech’s vaccine gets a green signal in India then that could also be an option for children.
It must be noted that the AIIMS has already started screening children for the same from June 7 onwards. The children considered for the trials are of age group 2-17.
The DCGI had on May 12 granted permission to Bharat Biotech to carry out phase 2, phase 3 trials of Covaxin on children as young as two.
Meanwhile, he reminded people of sticking with the coronavirus appropriate behaviour and always wear mask in public and maintain social distance.
Recently, he had alerted that the third wave will hit the nation in next 4-6 weeks as people have been seen flouting the rules in the public places.